https://novartis.com

NovartisWorking together, we can reimagine medicine to improve and extend people’s lives.Novartis Skip to main content Search Site Search Global | en Choose Location International Americas Asia Pacific Europe Middle East & Africa Global | English Novartis Foundation | English Argentina | Español Brazil | Português Canada | English Canada | Français Andean & CAC | Español Colombia | Español Mexico | Español United States | English Australia | English Hong Kong S.A.R. | 繁體中文 India | English Indonesia | English Japan | 日本語 Korea | 한국어 Mainland China | 中文 Malaysia | English Philippines | English Singapore | English Taiwan | 繁體中文 Thailand | ภาษาไทย Austria | Deutsch Belgium | Français Belgium | Nederlands Bulgaria | Български Czech Republic | Česky Czech Republic | English Denmark | Dansk Estonia | Eesti Finland | Suomalainen France | Français Germany | Deutsch Greece | Ελληνικά Hungary | Magyar Ireland | English Italy | Italiano Latvia | Latvian Lithuania | Lithuanian Netherlands | Nederlands Norway | Norsk Poland | Polski Portugal | Português Romania | Română Russia | Русский Serbia | Srpski Slovakia | Slovensky Slovenia | Slovenščina Slovenia | English Spain | Español Sweden | Svenska Switzerland | Deutsch Switzerland | Français Türkiye | Türkçe Ukraine | українська United Kingdom | English Egypt | English Israel | עברית Saudi Arabia | العربية South Africa | English Global Choose Location international International Americas Asia Pacific Europe Middle East & Africa Argentina | Español Australia | English Austria | Deutsch Belgium | Français Belgium | Nederlands Brazil | Português Bulgaria | Български Canada | English Canada | Français Andean & CAC | Español Colombia | Español Czech Republic | Česky Czech Republic | English Denmark | Dansk Egypt | English Estonia | Eesti Finland | Suomalainen France | Français Germany | Deutsch Greece | Ελληνικά Hong Kong S.A.R. | 繁體中文 Hungary | Magyar India | English Indonesia | English Ireland | English Israel | עברית Italy | Italiano Japan | 日本語 Korea | 한국어 Latvia | Latvian Lithuania | Lithuanian Mainland China | 中文 Malaysia | English Mexico | Español Netherlands | Nederlands Norway | Norsk Global | English Novartis Foundation | English Philippines | English Poland | Polski Portugal | Português Romania | Română Russia | Русский Saudi Arabia | العربية Serbia | Srpski Singapore | English Slovakia | Slovensky Slovenia | Slovenščina Slovenia | English South Africa | English Spain | Español Sweden | Svenska Switzerland | Deutsch Switzerland | Français Taiwan | 繁體中文 Thailand | ภาษาไทย Türkiye | Türkçe Ukraine | українська United Kingdom | English United States | English Menu About  Board of Directors  Giovanni Caforio  Simon Moroney  Nancy C. Andrews  Ton Buechner  Patrice Bula  Elizabeth (Liz) Doherty  Ana de Pro Gonzalo  Bridgette Heller  Daniel Hochstrasser  Frans van Houten  Elizabeth McNally  John D. Young  Charlotte Pamer-Wieser  Executive Committee  Vasant (Vas) Narasimhan  Shreeram Aradhye  Victor Bulto  Aharon (Ronny) Gal  Karen L. Hale  Patrick Horber  Harry Kirsch  Rob Kowalski  Steffen Lang  Fiona Marshall  Lutz Hegemann  Teresa Jose  Michelle Weese  Products  Therapeutic areas  Cardiovascular, renal and metabolic  Immunology  Neuroscience  Oncology  People and culture  Inclusion  Promoting inclusion  Building belonging  Parental leave  Caring for the mental health and wellbeing of our people  Novartis Gene Therapies  Manufacturing  Quality  Novartis quality management system (QMS)  Audit program and regulatory inspections  Product and patient safety training  Product recalls  Third-party suppliers  Novartis and the European Union (EU)  Awards and recognition  About Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 296 million people worldwide. Patients and caregivers  Novartis commitment to patients and caregivers  Diseases  Patient organization funding  Patients perspectives stories  Patients and caregivers Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting. Healthcare professionals  Medical congresses and events  ASCO Annual Meeting  Products  Novartis pipeline  Managed access programs  Zolgensma® Global Managed Access Program (gMAP)  Novartis external funding  Healthcare professional resources by country  Investigator-initiated trials / studies  Novartis medical information  Submit medical enquiry  Healthcare professionals Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information. Research and development  Technology platforms  Research disease areas  Cardiovascular and metabolic disease research at Novartis  Diseases of Aging and Regenerative medicine (DARe)  DAx: exploratory disease research at Novartis  Global Health disease area research at Novartis  Immunology disease research at Novartis  Neuroscience research at Novartis  Oncology research at Novartis  Novartis pipeline  Research collaborations  Collaborations  Research & development Discover how Novartis turns breakthrough science into transformative, high-value treatments.  ESG  Access  Creating sustainable business models  Value-based pricing  Sub-Saharan Africa  Donations  Novartis access principles  Novartis oncology access  Patents and licensing  Environmental sustainability  Climate  Nature - Waste  Nature - Water  Ethics, risk and compliance  Ethical behavior  Compliance  Human rights  Learning and engagement  Integrated risk assurance  Global health  Pandemic preparedness  Avoidable blindness  Chagas disease  Leprosy  Malaria  Sickle cell disease (SCD)  Novartis Foundation  Inclusion  ESG index  Reporting and transparency hub  ESG rating performance  Patient organization funding  Payments to healthcare professionals  Public policy  Animal research  Environmental, social and governance Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report. Investors  Event calendar  Financial data  Novartis annual results  Novartis quarterly results  Novartis SEC filings  Product sales  Fixed-income securities  Expected currency impact  Share data and analysis  Share monitor  Dividend information  Share ownership  Share overview  Return on investment calculator  Shareholder information  General Meetings  American Depositary Receipts (ADR)  Share buyback  Frequently asked questions  Company overview  Corporate governance  Reporting and transparency hub  Reporting archive  ESG rating performance  Publications order form  ESG  Investors Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting. News  Newsroom  Media library   Stories  Subscribe  Events  News Information for journalists including press releases, statements, stories, multimedia resources and more. Careers  Career search  Our business functions  Careers in research and development  Careers in operations  Careers in commercial and sales  Careers in global functions  Why Novartis  Career hub  Temporary contracts  Early careers  Graduates  Students  US Biomedical Research internship programs  Community exploration and learning lab (CELL)  Careers Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today. Clinical trials  Partnering  Supplier portal  Report side effects  Contacts  Home Working together, we can reimagine medicine to improve and extend people’s lives. Header Reimagining medicine, together Discover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients. Explore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives. Learn about our impact Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective. Novartis 2025 Financial Results Novartis announces the company’s fourth quarter and 2025 full year financial results. Learn more Annual reporting suite Explore and download our Annual Report 2025, Report on Nonfinancial Matters 2025 and other reporting documents. Learn more Latest news Feb 06, 2026 Press release Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery Feb 04, 2026 Ad hoc release Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025 Jan 16, 2026 Press release Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease All news Manufacturing expansion in the United States Novartis is expanding our manufacturing and R&D facilities in the US to scale innovation, help patients and create jobs. Learn more Bringing breakthroughs to more patients At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of innovation lies in its ability to improve lives. Read our full statement Welcome to where we thrive together Improving the lives of people living with disease takes more than innovative science. It takes a focus on the needs of people and a community committed to meeting them. It takes a team of people like you. Careers at Novartis Live. Magazine Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company. Learn more Resource links About Novartis Healthcare professionals Patients and caregivers Pipeline Products Novartis Working together Working together Patients and caregivers Healthcare professionals Researchers Job seekers Journalists Investors Topics Topics Q4 2025 Access ESG SpeakUp Explore Explore Pipeline Products Clinical trials Partnering Events Therapeutic areas Therapeutic areas Cardiovascular, renal and metabolic Immunology Neuroscience Oncology Footer Site Search Footer Bottom Footer Bottom © 2026 Novartis AG Terms of use Privacy Cookie settings Contacts Locations Site map Open source Web accessibility Novartis Site Directory This site is intended for a global audienceenen1770556109https://novartis.com

تعديل موقعك؟

ماذا تفعل؟